Clinical Trials on PD-1 Antibody in Luxembourg

Total 13 results

Centre Hospitalier du Luxembourg
University of Cambridge

Completed

Safety and Efficacy of Overnight Closed Loop in Children With Type 1Diabetes Mellitus in Luxembourg

Type 1 Diabetes Mellitus

Luxembourg
Luxembourg Institute of Health

Completed

Expectations of People With Type 1 Diabetes About Voice-based Interventions to Support Diabetes Distress Management (PSYVOICE)

Diabetes Distress | type1diabetes

Luxembourg
Centre Hospitalier du Luxembourg
University of Cambridge; Luxembourg Institute of Health

Completed

Adolescence and Diabetes:Can an Automated Closed Loop System Improve Control ? (SPIDIMAN2)

Type1 Diabetes Mellitus

Luxembourg
Centre Hospitalier du Luxembourg

Completed

QUality of Control and slEep in Children With diabeteS, Using New Technology (QUEST)

Diabetes Mellitus, Type 1

Luxembourg
University of Cambridge
Medical University of Graz; Medical University of Vienna; The Leeds Teaching... and other collaborators

Completed

The Artificial Pancreas in Very Young Children With T1D - Pilot (KidsAP01)

Type 1 Diabetes Mellitus

United Kingdom, Austria, Germany, Luxembourg
Novo Nordisk A/S

Completed

Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes (ADAPT)

Diabetes | Diabetes Mellitus, Type 1

France, Belgium, Luxembourg
University of Cambridge
Medical University of Graz; Medical University of Vienna; The Leeds Teaching... and other collaborators

Completed

The Artificial Pancreas in Very Young Children With T1D (KidsAP02)

Type 1 Diabetes Mellitus

United Kingdom, Austria, Germany, Luxembourg
Medtronic Diabetes

Completed

SWITCH - Sensing With Insulin Pump Therapy to Control HbA1c (SWITCH)

Diabetes Mellitus, Type 1

Netherlands, Slovenia, Denmark, Austria, Italy, Luxembourg, Spain
University of Cambridge
Juvenile Diabetes Research Foundation; The Leona M. and Harry B. Helmsley Charitable... and other collaborators

Unknown

An Innovative Approach Towards Understanding and Arresting Type 1 Diabetes (INNODIA) (INNODIA)

Type 1 Diabetes Mellitus

Austria, Italy, Finland, Denmark, Germany, Belgium, United Kingdom, France, Luxembourg, Norway, Poland, Slovenia, Sweden
Rigshospitalet, Denmark
Horizon 2020 - European Commission; IrsiCaixa

Not yet recruiting

The MISTRAL Study: Gut Microbiome Correlates of Serious AIDS and Non-AIDS Events (MISTRAL)

Inflammation | HIV-1-infection | AIDS

Spain, United Kingdom, Denmark, France, Israel, Germany, Belgium, Croatia, Czechia, Greece, Hungary, Italy, Luxembourg, Poland
University of Helsinki
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

TRIGR - Primary Prevention Study for Type 1 Diabetes in Children at Risk (TRIGR)

Diabetes Mellitus, Type 1

Spain, Luxembourg, Australia, Switzerland, Canada, Germany, Hungary, United States, Czechia, Estonia, Finland, Italy, Netherlands, Poland, Sweden
Tibotec Pharmaceuticals, Ireland

Completed

The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-term Safety and Tolerability of TMC125 Combined With Other Antiretroviral Drugs

HIV-1

United States, Belgium, Germany, Taiwan, Spain, Mexico, Turkey, Canada, Netherlands, Denmark, Greece, Sweden, Korea, Republic of, Russian Federation, Puerto Rico, Luxembourg
Novo Nordisk A/S

Completed

Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.

Diabetes Mellitus, Type 1

United Kingdom, Denmark, Sweden, Netherlands, Belgium, Finland, France, Australia, Ireland, Norway

Clinical Trials on PD-1 Antibody in Luxembourg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations